Urology · Indianapolis, IN
NPI
1629202197
Since 2009
Specialty
Urology
Code 208800000X
Group practices
9
Medicare group memberships
Hospitals
5
Hospital affiliations
1801 N Senate Blvd, Suite 220
Indianapolis, IN, 46202
Phone (317) 962-3886
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
371 services
Medicare patients, 2024
170
Average age 68
Drug cost, 2024
$227K
750 prescriptions
Company payments, 2025
$17K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Borofsky was code 99213 (office e&m - established), 47 times for 41 patients. In total Michael S Borofsky billed 371 services in 38 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 47 | 41 | $59.76 | $2,809 |
| 74420 Standard X-ray | Facility | 43 | 34 | $18.54 | $797 |
| 99214 Office E&M - Established | Office | 39 | 37 | $87.18 | $3,400 |
| 99204 Office E&M - New | Office | 26 | 26 | $109.45 | $2,846 |
| 52356 Calculus Removal - Urinary | Facility | 24 | 21 | $286.76 | $6,882 |
| 52000 Cystourethroscopy | Office | 23 | 23 | $166.98 | $3,840 |
| 51798 Ultrasound - Nonspecific | Office | 22 | 19 | $8.09 | $178 |
| 52649 Prostate Resection | Facility | 20 | 20 | $614.08 | $12K |
| 52332 Cystourethroscopy | Facility | 18 | 12 | $121.63 | $2,189 |
By year: 2022 $70K for 449 services; 2023 $74K for 473 services; 2024 $54K for 371 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Borofsky prescribed most often to Medicare patients was Tamsulosin Hcl, with 186 prescriptions and refills. In total Michael S Borofsky wrote 750 Medicare prescriptions that cost $227K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 186 | 354 | 71 | $1,997 |
| Finasteride Generic | 48 | 102 | 12 | $910 |
| Ciprofloxacin Hcl Generic | 41 | 41 | 32 | $197 |
| Potassium Citrate Er Potassium Citrate | 40 | 104 | 15 | $6,759 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 33 | 39 | 21 | $329 |
| Chlorthalidone Generic | 33 | 95 | 11 | $853 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 30 | 31 | 25 | $361 |
| Cephalexin Generic | 29 | 29 | 25 | $125 |
| Potassium Chloride Generic | 27 | 55 | Under 11 | $724 |
| Gentamicin Sulfate Generic | 26 | 26 | Under 11 | $2,886 |
| Myrbetriq Mirabegron | 25 | 41 | Under 11 | $18K |
| Thiola Ec Tiopronin | 24 | 24 | Under 11 | $183K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 21 | 63 | Under 11 | $518 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 | 20 | 18 | $76.03 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 18 | 14 | $88.3 |
Brand drugs: - claims; generic drugs: 678 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Borofsky $17K ($17K in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.